newsfilter
← Latest News
PR Newswire·

DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the...